A database of privately and publicly funded clinical studies conducted around the world from 220 countries shows that there are 5,934 registered clinical studies in the Russian Federation and over 2,400 in Ukraine, not to mention over 300 in Belarus.
“Through our partnership with Validcare we can offer the empir- ical results of more facile connections with our trial participants through e-CRF, e-diaries and more
“During this season of giving, Farmacon Global is pleased to announce LINK, our 2022 corporate social responsibility pro gram,” said Sara Tylosky, CEO Farmacon Global.
Save the Date for Farmacon Global and USC San Diego Extension’s Rare Disease Assembly, September 9th, 2021.
“This year our Rare Disease Assembly, called ‘Rare Diem – Seizing Opportunities for Rare Diseases in EmergingMarkets’ will be virtual,” said Sara Tylosky, CEO, Farmacon